Article Information
History
- September 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Chenfeng He1,2,#,
- Riyo Konishi1,#,
- Ayano Harata1,
- Yuki Nakamura1,2,
- Rin Mizuno1,
- Mayuko Yoda3,
- Masakazu Toi2,
- Kosuke Kawaguchi2,* and
- Shinpei Kawaoka1,3,*
- 1Inter-Organ Communication Research Team, Institute for Frontier Life and Medical Sciences, Kyoto, 606-8507, Japan
- 2Department of Breast Surgery, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
- 3Department of Integrative Bioanalytics, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai 980-8575, Japan
- ↵*Corresponding Authors: Kosuke Kawaguchi, MD, Ph.D., Breast Cancer Unit, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaracho, Sakyo-ku, Kyoto 606-8507, Japan, TEL: +81-75-751-3660, FAX: +81-75-751-3616, Email: kkosuke{at}kuhp.kyoto-u.ac.jp, Shinpei Kawaoka, Ph.D., Department of Integrative Bioanalytics, Institute of Development, Aging and Cancer (IDAC), Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan, TEL: +81-22-717-8568, Email: kawaokashinpei{at}gmail.com
↵# These authors equally contributed to this work. The order of their names is exchangeable.
Posted September 28, 2022.
Serum amyloid alpha 1-2 are not required for systemic inflammation in the 4T1 murine breast cancer model
